Skip to content
Main Menu
Home
Company
Pipeline
Products
Technology
News
Careers
Contact
NEWS
All
Corporate News
Corporate News
GNQ Insilico Secures MindLab, an Award Winning Pharma Company, as a Client for its Drug Assessment Platform
October 30, 2025
Read More →
Corporate News
GNQ Insilico Launches Revolutionary AI-Driven Assessment Platform to Transform Precision Medicine and Drug Development
September 10, 2025
Read More →
Corporate News
GNQ Insilico Unveils Multi-Pathway Therapeutic Formulation for ALS Leveraging proprietary Drug Assessment Platform
July 9, 2025
Read More →
Corporate News
GNQ’s Drug Assessment Platform Enhances Non-Small Cell Lung Cancer Treatment by Extending Efficacy Beyond Universal Resistance Barrier
July 7, 2025
Read More →
Corporate News
GNQ presents at Quantum Rising Conference alongside Deloitte & IBM Quantum
December 15, 2024
Read More →
Corporate News
GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug on Synthesized Digital Twins
June 18, 2024
Read More →
